| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $267K | — |
| SG&A Expense | $651K | +890.5% |
| Operating Income | -$918K | -1296.7% |
| Net Income | -$1.1M | -920.2% |
| EPS (Basic) | -$0.01 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Current Assets | $0 | -100.0% |
| Total Assets | $80K | +3193.8% |
| Current Liabilities | $849K | +43.7% |
| Total Liabilities | $896K | +51.7% |
| Stockholders' Equity | -$816K | -38.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53K | -50.1% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $50K | +39.6% |